Citadel Advisors
NUS icon

Citadel Advisors’s Nu Skin NUS Stock Holding History

Citadel Advisors’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,800
Closed -$63.9K – 14262
2025
Q1 		$63.9K Buy
8,800
+2,100
+31% +$15.3K ﹤0.01% 12031
2024
Q4 		$46.2K Sell
6,700
-4,100
-38% -$28.2K ﹤0.01% 12471
2024
Q3 		$79.6K Sell
10,800
-5,400
-33% -$50.5K ﹤0.01% 11419
2024
Q2 		$171K Sell
16,200
-4,400
-21% -$55.8K ﹤0.01% 10160
2024
Q1 		$285K Buy
20,600
+3,100
+18% +$48.4K ﹤0.01% 9559
2023
Q4 		$340K Buy
17,500
+3,600
+26% +$66.4K ﹤0.01% 8917
2023
Q3 		$295K Sell
13,900
-500
-3% -$13K ﹤0.01% 9212
2023
Q2 		$478K Sell
14,400
-2,600
-15% -$95.7K ﹤0.01% 8039
2023
Q1 		$668K Hold
17,000
– – ﹤0.01% 7689
2022
Q4 		$717K Sell
17,000
-13,800
-45% -$531K ﹤0.01% 7489
2022
Q3 		$1.03M Sell
30,800
-17,300
-36% -$720K ﹤0.01% 6924
2022
Q2 		$2.08M Buy
48,100
+23,200
+93% +$1.06M ﹤0.01% 5464
2022
Q1 		$1.19M Sell
24,900
-10,600
-30% -$525K ﹤0.01% 7304
2021
Q4 		$1.8M Sell
35,500
-23,800
-40% -$1.06M ﹤0.01% 6484
2021
Q3 		$2.4M Buy
59,300
+36,100
+156% +$1.83M ﹤0.01% 5900
2021
Q2 		$1.31M Buy
23,200
+15,100
+186% +$860K ﹤0.01% 7638
2021
Q1 		$428K Buy
8,100
+1,100
+16% +$59.9K ﹤0.01% 10032
2020
Q4 		$382K Sell
7,000
-8,200
-54% -$431K ﹤0.01% 8650
2020
Q3 		$761K Sell
15,200
-8,200
-35% -$389K ﹤0.01% 6540
2020
Q2 		$895K Buy
23,400
+3,400
+17% +$109K ﹤0.01% 6036
2020
Q1 		$437K Buy
20,000
+4,300
+27% +$129K ﹤0.01% 6689
2019
Q4 		$643K Buy
15,700
+3,200
+26% +$131K ﹤0.01% 6395
2019
Q3 		$532K Sell
12,500
-13,100
-51% -$550K ﹤0.01% 6632
2019
Q2 		$1.26M Sell
25,600
-12,600
-33% -$641K ﹤0.01% 5320
2019
Q1 		$1.83M Buy
38,200
+25,600
+203% +$1.55M ﹤0.01% 4610
2018
Q4 		$773K Sell
12,600
-4,200
-25% -$283K ﹤0.01% 5711
2018
Q3 		$1.39M Sell
16,800
-1,100
-6% -$87.4K ﹤0.01% 4992
2018
Q2 		$1.4M Buy
17,900
+7,000
+64% +$542K ﹤0.01% 4658
2018
Q1 		$803K Sell
10,900
-15,100
-58% -$1.07M ﹤0.01% 5136
2017
Q4 		$1.77M Buy
26,000
+14,100
+118% +$912K ﹤0.01% 3803
2017
Q3 		$732K Sell
11,900
-6,500
-35% -$399K ﹤0.01% 4778
2017
Q2 		$1.16M Sell
18,400
-3,900
-17% -$222K ﹤0.01% 3882
2017
Q1 		$1.24M Buy
22,300
+9,200
+70% +$474K ﹤0.01% 3700
2016
Q4 		$626K Sell
13,100
-58,800
-82% -$3.29M ﹤0.01% 4555
2016
Q3 		$4.66M Buy
71,900
+18,900
+36% +$1.06M ﹤0.01% 2057
2016
Q2 		$2.45M Sell
53,000
-106,000
-67% -$4.27M ﹤0.01% 2530
2016
Q1 		$6.08M Buy
159,000
+88,700
+126% +$2.93M 0.01% 1583
2015
Q4 		$2.66M Buy
70,300
+26,400
+60% +$973K ﹤0.01% 2450
2015
Q3 		$1.81M Sell
43,900
-42,300
-49% -$1.82M ﹤0.01% 3070
2015
Q2 		$4.06M Buy
86,200
+23,400
+37% +$1.27M ﹤0.01% 2253
2015
Q1 		$3.78M Sell
62,800
-84,100
-57% -$4.28M ﹤0.01% 2331
2014
Q4 		$6.42M Buy
146,900
+42,300
+40% +$1.87M 0.01% 1755
2014
Q3 		$4.71M Buy
104,600
+39,200
+60% +$2.09M ﹤0.01% 2041
2014
Q2 		$4.84M Sell
65,400
-75,000
-53% -$5.91M 0.01% 1856
2014
Q1 		$11.6M Buy
140,400
+13,100
+10% +$1.15M 0.01% 1168
2013
Q4 		$17.6M Buy
127,300
+50,600
+66% +$5.96M 0.02% 877
2013
Q3 		$7.34M Buy
76,700
+15,900
+26% +$1.35M 0.01% 1296
2013
Q2 		$3.72M Buy
+60,800
New +$3.38M 0.01% 1850

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Citadel Advisors's NUS Position: Q1 2026 in Review

Citadel Advisors opened a new position in Nu Skin (NUS) in Q1 2026: 227,385 shares worth $1.66M. The stake represents ﹤0.01% of the portfolio and ranks #6509 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NUS as recently as Q3 2025.

Citadel Advisors first reported a position in NUS in Q2 2013 and has held it in 49 quarters since. The position peaked at $31.5M in Q2 2019. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Citadel Advisors held 227,385 shares of Nu Skin worth $1.66M as of Q1 2026.
  • Nu Skin was a new Citadel Advisors position in Q1 2026.
  • Nu Skin made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6509 holding.
  • Citadel Advisors first reported a position in Nu Skin in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Nu Skin position peaked at $31.5M in Q2 2019.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.